ArticleCancer2016

Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.

Yago Nieto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.